APPLICATION
ANDA076999
TYPE
ANDA
ORIGINAL APPROVAL
2012-05-17
LATEST ACTION
2024-07-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
CLOPIDOGREL BISULFATEPrescription
CLOPIDOGREL BISULFATE EQ 75MG BASE · TABLET · ORAL
Approval history
2024-07-22Labeling · Supplement 17 · standardAP
2024-07-22Labeling · Supplement 16 · standardAP
2020-03-24Labeling · Supplement 14 · standardAP
2020-03-24Labeling · Supplement 12 · standardAP
2020-03-24Labeling · Supplement 10 · standardAP
2020-03-24Labeling · Supplement 13 · standardAP
2020-03-24Labeling · Supplement 11 · standardAP
2015-10-28Labeling · Supplement 7 · standardAP
2015-03-09Labeling · Supplement 6 · standardAP
2015-03-09Labeling · Supplement 2 · standardAP
2015-03-09Labeling · Supplement 3 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.